June 7, 2010 — Low-dose, transdermal hormone replacement therapy (HRT) does not appear to increase the risk for stroke compared with no HRT use, according to a study published June 3 in the BMJ. In ...

Proteins and peptides now constitute a major proportion of therapeutic modalities being pursued for the treatment of various diseases 1. Nearly 30% of all drugs approved by the US Food and Drug ...

Hormone replacement therapy skin patches containing low doses of estrogen carry less risk of stroke than oral therapy and may represent a safer alternative to tablets, a new study suggests. Hormone ...

The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with transdermal drug ...

Drug administration to neonates often requires prolonged intravenous access, mostly because of either poor gastrointestinal function or poor oral bioavailability of the drugs being used. Transdermal ...

Please provide your email address to receive an email when new articles are posted on . Risk for venous thromboembolism does not differ for women using oral conjugated equine estrogen vs. oral or ...

The optimal treatment for menopausal hot flashes is estrogen therapy. 4 Estrogen replacement results in a markedly greater reduction in the frequency and severity of hot flashes than placebo, as ...

Transdermal drug delivery is an alternative to oral or invasive drug delivery systems. This approach is associated with several advantages including its ability to bypass first-pass metabolism and its ...

A review in the Annals of Pharmacotherapy examined the literature on alternative routes of administration for antipsychotic and antidepressant medications via inhaled, intranasal, buccal, sublingual, ...

Research and Markets (http://www.researchandmarkets.com/research/8cqjfl/novel) has announced the addition of the "Novel Applications of Drug Delivery Technologies ...